134774-45-1
Post Buying Request-
-
Basic information
- Product Name: Rasburicase
- Synonyms: Rasburicase;Elitek;Fasturtec
- CAS NO:134774-45-1
- Molecular Formula: C1523H2383N417O462S7
- Molecular Weight:
- EINECS: N/A
- Product Categories: N/A
- Mol File: 134774-45-1.mol
- Article Data: 0
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: N/A
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: Rasburicase(CAS DataBase Reference)
- NIST Chemistry Reference: Rasburicase(134774-45-1)
- EPA Substance Registry System: Rasburicase(134774-45-1)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 134774-45-1(Hazardous Substances Data)
134774-45-1 Suppliers
Recommended suppliersmore
134774-45-1 Usage
Uses
Treatment of malignancyassociated or chemotherapy-induced hyperuricemia.Clinical Use
Prophylaxis and treatment of acute hyperuricaemia with initial chemotherapy for haematological malignancyDrug interactions
Potentially hazardous interactions with other drugs None knownMetabolism
Rasburicase is a protein; it is expected that metabolic degradation will follow the pathways of other proteins, i.e. peptide hydrolysis.Check Digit Verification of cas no
The CAS Registry Mumber 134774-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,7,7 and 4 respectively; the second part has 2 digits, 4 and 5 respectively.Calculate Digit Verification of CAS Registry Number 134774-45:
(8*1)+(7*3)+(6*4)+(5*7)+(4*7)+(3*4)+(2*4)+(1*5)=141
141 % 10 = 1
So 134774-45-1 is a valid CAS Registry Number.
134774-45-1Upstream product
134774-45-1Downstream Products
134774-45-1Related news
Effectiveness of Single-dose Rasburicase (cas 134774-45-1) in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome07/30/2019
BackgroundTumor lysis syndrome (TLS) is a life-threatening disorder that occurs mainly in patients with high-tumor burden hemato-oncologic malignancies. It results in metabolic derangements, including hyperuricemia and acute renal failure. The powerful management for TLS is a daily dose of rasbu...detailed
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 134774-45-1
Rasburicase
